Butterbur extract: prophylactic treatment for childhood migraines

Gretchann Utterback1, Rayna Zacharias1, Shahrazad Timraz1

  • 1Wayne State University, College of Nursing, 5557 Cass Avenue, Detroit, MI 48202, USA.

Insights

Pediatric migraines are increasing and difficult to treat. Butterbur extract offers a promising natural alternative for preventive treatment in children when conventional therapies fail.

Area of Science:

  • Neurology
  • Pediatrics
  • Pharmacology

Background:

  • Childhood migraine incidence is rising, posing diagnostic and therapeutic challenges.
  • Disabling pediatric migraines significantly impact children and families, necessitating effective prevention.
  • Current prophylactic medications have limitations, including side effects and questionable efficacy.

Purpose of the Study:

  • To discuss the impact of migraines in pediatric patients.
  • To review the rationale for preventative treatment of pediatric migraines.
  • To evaluate butterbur extract as a potential prophylactic therapy for pediatric migraines.

Main Methods:

  • Literature review on pediatric migraines, current treatments, and alternative therapies.
  • Analysis of the role of butterbur extract (Petasites hybridus) in migraine prevention.
  • Discussion of the relevance of natural remedies in pediatric migraine management.

Main Results:

  • Butterbur extract is identified as a promising natural remedy for pediatric migraine prevention.
  • The study highlights the need for alternative options due to limitations of conventional treatments.
  • Butterbur extract presents a viable option for patients and families seeking natural interventions.

Conclusions:

  • Butterbur extract shows potential as a safe and effective prophylactic treatment for pediatric migraines.
  • Further research is warranted to establish optimal dosing and long-term efficacy.
  • Natural remedies like butterbur extract are valuable additions to the migraine management toolkit for children.

Related Concept Videos

Cholinergic Antagonists: Therapeutic Uses01:26

Cholinergic Antagonists: Therapeutic Uses

Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:    
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
1.7K
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
1.7K
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
807
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
1.0K
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers01:27

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
1.8K
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
1.4K